JESSICA P HWANG to Hepatitis B virus
This is a "connection" page, showing publications JESSICA P HWANG has written about Hepatitis B virus.
Connection Strength
4.598
-
Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer. JCO Oncol Pract. 2022 09; 18(9):636-644.
Score: 0.739
-
USPSTF 2020 Hepatitis B Screening Recommendation: Evidence to Broaden Screening and Strengthen Linkage to Care. JAMA. 2020 12 15; 324(23):2380-2382.
Score: 0.666
-
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol. 2020 11 01; 38(31):3698-3715.
Score: 0.648
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.588
-
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer. 2017 Sep 01; 123(17):3367-3376.
Score: 0.520
-
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Oncol Pract. 2015 Jul; 11(4):e487-9.
Score: 0.452
-
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
Score: 0.407
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.
Score: 0.192
-
Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib. Clin Lymphoma Myeloma Leuk. 2020 03; 20(3):e124-e127.
Score: 0.156
-
Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
Score: 0.092
-
False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
Score: 0.048
-
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int. 2023 04; 17(2):509-511.
Score: 0.048
-
Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. J Viral Hepat. 2021 05; 28(5):844-848.
Score: 0.042